Enalapril and metoprolol in diabetic nephropathy.
出版信息
BMJ. 1990 May 26;300(6736):1399. doi: 10.1136/bmj.300.6736.1399.
Abstract
摘要
相似文献
1
Enalapril and metoprolol in diabetic nephropathy.依那普利与美托洛尔治疗糖尿病肾病
BMJ. 1990 May 26;300(6736):1399. doi: 10.1136/bmj.300.6736.1399.
2
Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy.依那普利与美托洛尔对糖尿病肾病蛋白尿的对比作用。
BMJ. 1990 Apr 7;300(6729):904-7. doi: 10.1136/bmj.300.6729.904.
3
Enalapril and metoprolol in diabetic nephropathy.依那普利与美托洛尔治疗糖尿病肾病
BMJ. 1990 Jun 2;300(6737):1466. doi: 10.1136/bmj.300.6737.1466-a.
4
Combining antihypertensive agents in early diabetic nephropathy.早期糖尿病肾病中联合使用抗高血压药物。
J Diabet Complications. 1990 Apr-Jun;4(2):88-90. doi: 10.1016/0891-6632(90)90044-6.
5
Renal protective effect of enalapril in diabetic nephropathy.依那普利对糖尿病肾病的肾脏保护作用。
BMJ. 1992 Feb 8;304(6823):339-43. doi: 10.1136/bmj.304.6823.339.
6
Renal protective effect of enalapril in diabetic nephropathy.依那普利对糖尿病肾病的肾脏保护作用。
BMJ. 1992 Mar 28;304(6830):841. doi: 10.1136/bmj.304.6830.841-a.
7
Long-term enalapril treatment in diabetic nephropathy.糖尿病肾病的长期依那普利治疗
Kidney Int Suppl. 1994 Feb;45:S141-4.
8
Enalapril retards glomerular basement membrane thickening and albuminuria in the diabetic rat: are these effects specific for enalapril?
Diabetologia. 1989 Nov;32(11):829. doi: 10.1007/BF00264916.
9
10
Discontinuing ACE inhibition in patients with diabetic nephropathy.
BMJ. 1991 Mar 16;302(6777):658. doi: 10.1136/bmj.302.6777.658.
本文引用的文献
1
Postmarketing surveillance of enalapril. II: Investigation of the potential role of enalapril in deaths with renal failure.依那普利上市后监测。II：依那普利在肾衰竭死亡中潜在作用的调查。
BMJ. 1988 Oct 1;297(6652):830-2. doi: 10.1136/bmj.297.6652.830.
2
Postmarketing surveillance of enalapril. I: Results of prescription-event monitoring.依那普利的上市后监测。I：处方事件监测结果。
BMJ. 1988 Oct 1;297(6652):826-9. doi: 10.1136/bmj.297.6652.826.
3
Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy.依那普利与美托洛尔对糖尿病肾病蛋白尿的对比作用。
BMJ. 1990 Apr 7;300(6729):904-7. doi: 10.1136/bmj.300.6729.904.
4
Do angiotensin converting enzyme inhibitors represent a progress in hypertension care in diabetes mellitus?
Diabetologia. 1990 Feb;33(2):121-4. doi: 10.1007/BF00401052.
Zotero 插件